Metropolitan Life Insurance Company (MetLife)’s Synchronoss Technologies SNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,411
Closed -$38.7K 2589
2020
Q1
$38.7K Buy
+1,411
New +$62.1K ﹤0.01% 2409
2019
Q4
Sell
-489
Closed -$23.8K 2557
2019
Q3
$23.8K Buy
489
+169
+53% +$11.5K ﹤0.01% 2543
2019
Q2
$22.8K Buy
+320
New +$18.1K ﹤0.01% 2592
2018
Q2
Sell
-1,606
Closed -$152K 2490
2018
Q1
$152K Buy
1,606
+217
+16% +$17.8K ﹤0.01% 2060
2017
Q4
$112K Sell
1,389
-1,781
-56% -$172K ﹤0.01% 2242
2017
Q3
$266K Hold
3,170
﹤0.01% 2104
2017
Q2
$469K Hold
3,170
﹤0.01% 1738
2017
Q1
$696K Hold
3,170
﹤0.01% 1432
2016
Q4
$1.09M Sell
3,170
-80
-2% -$30.1K 0.01% 1250
2016
Q3
$1.2M Hold
3,250
0.01% 1181
2016
Q2
$932K Buy
3,250
+39
+1% +$11.8K 0.01% 1298
2016
Q1
$935K Hold
3,211
0.01% 1215
2015
Q4
$1.02M Buy
3,211
+266
+9% +$88.2K 0.01% 1180
2015
Q3
$869K Hold
2,945
0.01% 1270
2015
Q2
$1.21M Sell
2,945
-96
-3% -$41.3K 0.01% 1167
2015
Q1
$1.3M Hold
3,041
0.01% 1065
2014
Q4
$1.15M Hold
3,041
0.01% 1245
2014
Q3
$1.25M Hold
3,041
0.01% 1147
2014
Q2
$957K Buy
3,041
+555
+22% +$159K 0.01% 1380
2014
Q1
$767K Hold
2,486
0.01% 1525
2013
Q4
$695K Hold
2,486
﹤0.01% 1578
2013
Q3
$852K Sell
2,486
-116
-4% -$35.3K 0.01% 1378
2013
Q2
$723K Buy
+2,602
New +$700K 0.01% 1452

Other funds holding SNCR

Metropolitan Life Insurance Company (MetLife)'s SNCR Position: Q2 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Synchronoss Technologies (SNCR) in Q2 2020, closing a stake of 1,411 shares — an estimated $38.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SNCR in Q2 2013 and held it in 23 quarters. The position peaked at $1.3M in Q1 2015. 82 funds tracked by Wall St. Rank hold SNCR as of Q2 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Synchronoss Technologies position as of Q2 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,411 Synchronoss Technologies shares in Q2 2020, an estimated $38.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Synchronoss Technologies in Q2 2013 and held it in 23 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Synchronoss Technologies position peaked at $1.3M in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Synchronoss Technologies as of Q2 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.